BioHemp (BKIT) Provides Guidance on Placing Trading Orders in Open Market

(NEW YORK)–BioHemp International (OTC:BKIT) is pleased to announce that as of Oct. 14, 2019 the company has begun the process to regain compliance to relist the company stock back current with OTC Markets. The Company has retained a law firm that specializes specifically in assisting companies in filing 15c-211 to regain trading compliance, and feel […]


BioHemp (BKIT) Provides Update to Shareholders

Dear Shareholders, I would like to thank you for joining our investor mailing list as we aim to establish better shareholder communications by utilizing email, and our social media platforms. The Company has been busy behind the scenes working to bring the company trading back “current” with OTC Markets. In meantime, we are embarking on […]